Cite
Ma X, Takahashi Y, Wu W, et al. Soluble very low-density lipoprotein receptor (sVLDLR) inhibits fibrosis in neovascular age-related macular degeneration. FASEB J. 2021;35(12):e22058doi: 10.1096/fj.202101334R.
Ma, X., Takahashi, Y., Wu, W., Chen, J., Dehdarani, M., Liang, W., Shin, Y. H., Benyajati, S., & Ma, J. X. (2021). Soluble very low-density lipoprotein receptor (sVLDLR) inhibits fibrosis in neovascular age-related macular degeneration. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 35(12), e22058. https://doi.org/10.1096/fj.202101334R
Ma, Xiang, et al. "Soluble very low-density lipoprotein receptor (sVLDLR) inhibits fibrosis in neovascular age-related macular degeneration." FASEB journal : official publication of the Federation of American Societies for Experimental Biology vol. 35,12 (2021): e22058. doi: https://doi.org/10.1096/fj.202101334R
Ma X, Takahashi Y, Wu W, Chen J, Dehdarani M, Liang W, Shin YH, Benyajati S, Ma JX. Soluble very low-density lipoprotein receptor (sVLDLR) inhibits fibrosis in neovascular age-related macular degeneration. FASEB J. 2021 Dec;35(12):e22058. doi: 10.1096/fj.202101334R. PMID: 34820908.
Copy
Download .nbib